Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Precision Medicine
MedTech
FDA OKs Illumina's tumor gene test as a companion diagnostic
The TruSight Oncology Comprehensive test screens solid tumor samples for 517 genes to help identify who may benefit from specific immunotherapies.
Conor Hale
Aug 28, 2024 12:00pm
Ex-Kite leader helms Santa Ana’s ship with $168M in hand
Jun 13, 2024 8:00am
Oculis sees promise in dry eye disease subgroup, plans phase 3
Jun 10, 2024 7:20am
Canadian VC Amplitude unveils $192M biotech fund
May 29, 2024 10:30am
COSMIC's v100 adds more than 300,000 new gene variants
May 21, 2024 11:00am
AI, DNA and drug testing tackles relapsed childhood cancers
Apr 11, 2024 6:00am